Article Information
History
- January 19, 2022.
Article Versions
- You are currently viewing Version 1 of this article (January 19, 2022 - 13:00).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Samantha E Greasley1,
- Stephen Noell2,
- Olga Plotnikova2,
- RoseAnn Ferre1,
- Wei Liu1,
- Ben Bolanos1,
- Kimberly Fennell2,
- Jennifer Nicki2,
- Tim Craig2,
- Yuao Zhu3,
- Al E Stewart1 and
- Claire M Steppan*,2
- 1Pfizer Worldwide Research, Development & Medical, La Jolla, CA, 92037, USA
- 2Pfizer Worldwide Research, Development & Medical, Groton, CT, 06340, USA
- 3Pfizer Worldwide Research, Development & Medical, Pearl River, NY, 10965,USA
- ↵*Corresponding Author Email: claire.m.steppan{at}pfizer.com